| Name | Title | Contact Details |
|---|
GD improves healthcare by developing the most comprehensive, interactive and widely-used mobile telemedicine, communication, and notification solutions for pre-hospital and hospital environments. Our affordable and completely customizable offerings empower EMS and medical teams to enhance workflows, and document, record and analyze interactions and patient data to minimize risk, reduce costs, and improve patient outcomes.
Devax is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carl Ziess is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.
NanoHybrids specializes in research and commercialization of nanotechnology-based products that enhance diagnosis and therapy for cancer and other diseases through enhanced molecular imaging and profiling. Our molecular imaging nanoparticles enhance contrast in vitro and in vivo across multiple biomedical imaging modalities. We are the leading provider of silica-coated gold nanoparticles optimized for photoacoustic (optoacoustic) imaging. With conjugation services we provide nanoparticles with high specificity for targeted cell receptors and tailored to individual applications. Our nanoparticles improve signal strength and allow real time imaging of functional biology. Interested in learning how we are using nanotechnology to drive advances in the life-sciences? Want learn more about our research, products, or services? Contact us, and let`s talk.